Bilirubinemia
Understanding bilirubinemia, also known as hyperbilirubinemia or jaundice, is crucial for accurate clinical documentation and medical coding. This resource provides information on bilirubinemia diagnosis, symptoms like jaundice, and relevant ICD-10 codes for healthcare professionals. Learn about neonatal jaundice, bilirubin levels, and treatment options for effective patient care and proper medical billing.
Yellowing of skin and eyes from excess bilirubin in blood.
Jaundice, dark urine, pale stools, itchy skin, fatigue.
Newborns, liver disease, gallbladder problems, blood disorders.
ICD-10 Code Families
Complete code families applicable to R17
When to use each related code
| Description | When to use |
|---|---|
| Yellowing of skin/eyes from excess bilirubin. | Use for elevated bilirubin levels causing visible jaundice. Consider underlying causes. |
| Neonatal jaundice, often physiological. | Use for jaundice in newborns within 28 days of life. Specify physiological vs pathological. |
| Obstructed bile flow causing jaundice. | Use when jaundice is due to blockage in bile ducts. Specify location/cause of obstruction. |
Best-practice checklist
- ✓Bilirubin level (total, direct, indirect)
- ✓Onset and duration of jaundice
- ✓Clinical signs of jaundice (e.g., scleral icterus, skin discoloration)
- ✓Underlying liver disease or hemolysis assessment
- ✓Neonatal bilirubinemia: gestational age, birth weight
Common pitfalls to avoid
Coding neonatal jaundice requires specifying physiological vs pathological and documenting cause, onset time, and treatment.
Bilirubinemia is a symptom. Coding requires documenting the underlying cause, such as liver disease or hemolysis.
For newborns, document kernicterus risk assessment, including bilirubin levels, gestational age, and risk factors.
Best-practice tips
- 01Timely bilirubin level monitoring, phototherapy for newborns.
- 02Identify underlying cause: hemolysis, liver disease, Gilbert's syndrome.
- 03Accurate ICD-10 coding (R17, P59) for proper reimbursement.
- 04Detailed clinical documentation of jaundice onset, progression.
- 05Patient education: feeding support, follow-up care, kernicterus risk.
Step-by-step checklist
- 1
Review total, direct, and indirect bilirubin levels (ICD-10 R17)
- 2
Assess patient age and risk factors for jaundice (newborn, hemolysis)
- 3
Evaluate for signs/symptoms: scleral icterus, dark urine, pale stools
- 4
Consider underlying liver disease, biliary obstruction (ICD-10 K70-K77, K80-K87)
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of bilirubinemia, potentially hyperbilirubinemia, manifested as jaundice. Clinical examination reveals yellowing of the skin and sclera. The patient's presenting complaint may include itching, fatigue, or abdominal discomfort. Differential diagnosis includes neonatal jaundice, physiological jaundice, breast milk jaundice, breastfeeding jaundice, hemolytic anemia, Gilbert's syndrome, Crigler-Najjar syndrome, biliary obstruction, and liver dysfunction. Laboratory tests, such as a comprehensive metabolic panel (CMP) including total bilirubin, direct bilirubin, and indirect bilirubin levels, liver function tests (LFTs), complete blood count (CBC), and possibly a peripheral blood smear, will be ordered to determine the underlying etiology of the elevated bilirubin and assess liver function. Further diagnostic testing, such as abdominal ultrasound or hepatobiliary iminodiacetic acid (HIDA) scan, may be indicated depending on the initial laboratory results. Treatment for bilirubinemia will be determined based on the cause and severity of the condition. Possible treatment options include phototherapy, intravenous fluids, exchange transfusion in severe neonatal cases, and management of the underlying condition. Patient education will be provided on the importance of follow-up care and monitoring of bilirubin levels. ICD-10 coding will be based on the specific etiology of the hyperbilirubinemia, such as R17 for unspecified jaundice or P59.9 for neonatal jaundice. CPT coding for procedures, such as phototherapy (99238) or exchange transfusion (36450), will be documented accordingly. Medical necessity for all diagnostic tests and treatment will be clearly documented in the patient's medical record.
Common questions and answers
What are the key differential diagnoses to consider when evaluating neonatal hyperbilirubinemia?+
When evaluating a neonate with hyperbilirubinemia, it's crucial to distinguish between physiological jaundice and pathological causes. Physiological jaundice typically peaks around day 3-5 of life and resolves within 1-2 weeks. However, pathological hyperbilirubinemia requires further investigation. Key differential diagnoses include ABO incompatibility, Rh incompatibility, G6PD deficiency, sepsis, hypothyroidism, biliary atresia, and breast milk jaundice. Distinguishing these requires careful assessment of the onset, duration, and pattern of jaundice, along with laboratory tests like total and direct bilirubin, blood type, Coombs test, and CBC. Consider implementing a diagnostic algorithm that incorporates risk factors like prematurity and bruising to efficiently narrow down the potential causes. Explore how different diagnostic tests can help pinpoint the underlying etiology of neonatal jaundice and guide appropriate management.
How does breastfeeding impact bilirubin levels in newborns, and when should breastfeeding jaundice be a concern?+
Breastfeeding can influence bilirubin levels in newborns through two distinct mechanisms: breastfeeding jaundice and breast milk jaundice. Breastfeeding jaundice typically occurs in the first week of life due to insufficient milk intake, leading to dehydration and decreased bilirubin excretion. Breast milk jaundice, however, appears later, around day 4-7, and may persist for several weeks. It's thought to be caused by factors in breast milk that inhibit bilirubin conjugation. While both are generally benign, they can sometimes lead to significant hyperbilirubinemia. Closely monitor the infant's hydration, weight gain, and stool output. If breastfeeding jaundice is suspected, optimizing breastfeeding technique and ensuring adequate milk intake are crucial. For breast milk jaundice, temporary interruption of breastfeeding may be considered in cases of severe hyperbilirubinemia, but it's important to weigh the risks and benefits with the mother. Learn more about the management strategies for breastfeeding-associated jaundice and how to support breastfeeding mothers during this period.
What are the evidence-based treatment options for significant unconjugated hyperbilirubinemia in neonates, and how do I choose the appropriate intervention?+
The primary concern with significant unconjugated hyperbilirubinemia is the risk of kernicterus, a neurological complication caused by bilirubin deposition in the brain. Treatment options are determined by the severity of hyperbilirubinemia and the underlying cause. Phototherapy is the first-line treatment for most cases, using specific wavelengths of light to convert bilirubin into a more water-soluble form that can be excreted. Intravenous immunoglobulin (IVIG) may be used for isoimmune hemolytic disease, while exchange transfusion is reserved for severe cases unresponsive to phototherapy or when kernicterus is suspected. Choosing the appropriate intervention requires careful monitoring of bilirubin levels, considering the gestational age, and assessing the presence of risk factors for kernicterus. Explore how nomograms can help guide treatment decisions for neonatal hyperbilirubinemia and ensure timely intervention to prevent complications.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.